Cargando…

What is the Business Case for Improving Care for Patients with Complex Conditions?

INTRODUCTION: Patients with complex conditions account for a disproportionate share of health care spending. Although evidence indicates that care for these patients could be provided more efficiently, the financial impact of mechanisms to improve the care they receive is unclear. DESIGN/METHODS: Nu...

Descripción completa

Detalles Bibliográficos
Autores principales: Luck, Jeff, Parkerton, Patricia, Hagigi, Fred
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150614/
https://www.ncbi.nlm.nih.gov/pubmed/18026808
http://dx.doi.org/10.1007/s11606-007-0293-2
_version_ 1782144634265272320
author Luck, Jeff
Parkerton, Patricia
Hagigi, Fred
author_facet Luck, Jeff
Parkerton, Patricia
Hagigi, Fred
author_sort Luck, Jeff
collection PubMed
description INTRODUCTION: Patients with complex conditions account for a disproportionate share of health care spending. Although evidence indicates that care for these patients could be provided more efficiently, the financial impact of mechanisms to improve the care they receive is unclear. DESIGN/METHODS: Numerous mechanisms—emphasizing patient self-management, care coordination, and evidence-based guidelines—aim to improve the quality of care and outcomes for patients with complex conditions. Assessing the overall “business case” for these mechanisms requires carefully estimating all relevant costs and financial benefits, then comparing them in present value terms. Mechanisms that are not cost-saving may still be implemented if they are cost-effective. We reviewed articles in peer-reviewed journals, as well as reports available on publicly accessible websites, which contained data about the business case for mechanisms to improve care for patients with complex conditions. MAIN RESULTS: Published studies do not provide clear evidence that current mechanisms are cost saving. This literature also has several major methodological shortcomings with respect to providing an understanding of the business case for these mechanisms. CONCLUSIONS: Further research using standardized methodologies is needed to understand the business case for mechanisms to improve care for patients with complex conditions. Implications for VA business case analyses include the necessity of establishing appropriate time horizons, scope of services, and target populations, as well as considering the impact of existing VA systems.
format Text
id pubmed-2150614
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-21506142008-05-06 What is the Business Case for Improving Care for Patients with Complex Conditions? Luck, Jeff Parkerton, Patricia Hagigi, Fred J Gen Intern Med Original Article INTRODUCTION: Patients with complex conditions account for a disproportionate share of health care spending. Although evidence indicates that care for these patients could be provided more efficiently, the financial impact of mechanisms to improve the care they receive is unclear. DESIGN/METHODS: Numerous mechanisms—emphasizing patient self-management, care coordination, and evidence-based guidelines—aim to improve the quality of care and outcomes for patients with complex conditions. Assessing the overall “business case” for these mechanisms requires carefully estimating all relevant costs and financial benefits, then comparing them in present value terms. Mechanisms that are not cost-saving may still be implemented if they are cost-effective. We reviewed articles in peer-reviewed journals, as well as reports available on publicly accessible websites, which contained data about the business case for mechanisms to improve care for patients with complex conditions. MAIN RESULTS: Published studies do not provide clear evidence that current mechanisms are cost saving. This literature also has several major methodological shortcomings with respect to providing an understanding of the business case for these mechanisms. CONCLUSIONS: Further research using standardized methodologies is needed to understand the business case for mechanisms to improve care for patients with complex conditions. Implications for VA business case analyses include the necessity of establishing appropriate time horizons, scope of services, and target populations, as well as considering the impact of existing VA systems. Springer-Verlag 2007-11-16 2007-12 /pmc/articles/PMC2150614/ /pubmed/18026808 http://dx.doi.org/10.1007/s11606-007-0293-2 Text en © Society of General Internal Medicine 2007
spellingShingle Original Article
Luck, Jeff
Parkerton, Patricia
Hagigi, Fred
What is the Business Case for Improving Care for Patients with Complex Conditions?
title What is the Business Case for Improving Care for Patients with Complex Conditions?
title_full What is the Business Case for Improving Care for Patients with Complex Conditions?
title_fullStr What is the Business Case for Improving Care for Patients with Complex Conditions?
title_full_unstemmed What is the Business Case for Improving Care for Patients with Complex Conditions?
title_short What is the Business Case for Improving Care for Patients with Complex Conditions?
title_sort what is the business case for improving care for patients with complex conditions?
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150614/
https://www.ncbi.nlm.nih.gov/pubmed/18026808
http://dx.doi.org/10.1007/s11606-007-0293-2
work_keys_str_mv AT luckjeff whatisthebusinesscaseforimprovingcareforpatientswithcomplexconditions
AT parkertonpatricia whatisthebusinesscaseforimprovingcareforpatientswithcomplexconditions
AT hagigifred whatisthebusinesscaseforimprovingcareforpatientswithcomplexconditions